Clinical trials
Ischemic Stroke clinical trials
Below are recruiting ischemic stroke clinical trials, each written for real people, not researchers. We’re tracking 577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07419997Recruiting
Observational study on clot-busting drugs beyond the usual window
This study looks at patients who received a clot-busting drug (intravenous thrombolysis) for their stroke 4.5 to 24 hours after symptoms started. It aims to see how well this works and what happens to them, using data that has already been collected.
BeijingAges 18 years+ - NCT07519044RecruitingPhase 4
GM1 drug added to clot removal for acute stroke
This study tests whether adding a medicine called GM1 to emergency clot-removal surgery helps people recover better from sudden strokes caused by blood clots in major brain arteries. GM1 may protect brain cells from damage during and after the stroke.
Beijing, Beijing MunicipalityAges 18–80 - NCT06961487Enrolling by invitation
Stroke treatment trial for large area brain damage
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
Palo Alto, CaliforniaAges 18–90 - NCT06781385Enrolling by invitationPhase 2
Tenecteplase after clot removal for severe stroke
This trial tests if giving a clot-busting drug (tenecteplase) directly into the brain artery after a successful clot-removal procedure can improve outcomes for people with a major stroke. It is for patients who had a large vessel blockage and received endovascular thrombectomy within 24 hours of symptoms starting.
Charlotte, North CarolinaAges 18 years+ - NCT06551727Enrolling by invitation
Stroke progression treatment: blood pressure and antiplatelet therapy
This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07479147Recruiting
Stroke prevention in elderly by PFO closure vs blood thinners
This trial compares two treatments for preventing another stroke in older adults who have a PFO (a small hole in the heart). It tests whether closing the hole with a device works better than using blood-thinning medication.
TaichungAges 18–90 - NCT06492265RecruitingPhase 2
Emergency stroke unit study for acute brain attacks
This trial tests a special stroke unit for people having a severe ischemic stroke (a blood clot in the brain). It aims to see if treatment within 4.5 to 6 hours after symptoms start can improve recovery. You may join if you need a procedure to remove the clot.
BeijingAges 18 years+ - NCT06522282RecruitingPhase 3
Testing Emergency Stroke Unit for Acute Stroke (4.5-6 hours)
This trial tests a new way to treat ischemic stroke patients who arrive at the hospital 4.5 to 6 hours after symptoms start. It focuses on people eligible for a clot removal procedure, using advanced imaging to see if this approach helps them recover better.
BeijingAges 18 years+ - NCT07083986Enrolling by invitation
Surgery vs stenting for recent stroke patients
This trial compares two procedures to open a blocked carotid artery in people who recently had a stroke. One option is surgery (carotid endarterectomy) to remove the blockage, the other is stenting (placing a small mesh tube to hold the artery open). The goal is to see which works better for patients still having some stroke symptoms.
MoscowAges 18 years+ - NCT07085390Recruiting
Comparing two catheters for stroke clot removal
This study compares two types of catheters (thin tubes) used during a stroke procedure to remove a blood clot. The goal is to see which one works better for clearing blockages in large blood vessels in the brain.
Tampa, FloridaAges 18 years+ - NCT03720522Recruiting
Study brain-heart signals in acute stroke using MRI
This study looks at how the brain and heart interact right after an acute ischemic stroke. It may help doctors better understand what happens in the first hours of stroke and improve monitoring or future treatments.
Bern, Canton of BernAges 18–86 - NCT03737786Recruiting
Sedation with collateral support for stroke clot removal
This trial tests a specific sedation approach, along with support during the procedure, for people having emergency clot removal (mechanical thrombectomy) for a certain type of acute ischemic stroke. It may help make the procedure safer and more effective by improving how patients are managed during endovascular treatment.
Los Angeles, CaliforniaAges 18–110 - NCT04862507Recruiting
Thrombectomy treatment for severe stroke with low ASPECTS
This trial studies an approach for removing a blockage using thrombectomy in people with an acute ischemic stroke that shows a low ASPECTS score. It may help restore blood flow in strokes that have significant early changes on brain imaging.
BerlinAges 18 years+ - NCT04975646Recruiting
Goal-setting tool for upper-arm spasticity treatment
This study looks at whether a structured goal-setting approach helps measure and improve treatment for stiff, tight upper-arm muscles after a stroke. It tests how well patients’ (or caregivers’) goals can be tracked when receiving or considering botulinum toxin (BTX-A).
LjubljanaAges 18 years+ - NCT05303649Recruiting
Theta burst brain stimulation for language problems after stroke
This study tests whether a type of brain stimulation guided by a brain scan (MRI) can improve speech and language (“aphasia”) after a stroke. It may help people who have trouble producing speech but can still understand others’ words.
Warsaw, Masovian VoivodeshipAges 18–75 - NCT05556395Recruiting
Study after stroke to help thinking and memory recovery
This trial looks at stroke patients who can show specific scan findings on an MRI, then uses thinking tests by phone to track cognitive (thinking and memory) changes. It may help researchers understand whether targeting brain blood-flow disruption can improve post-stroke cognition.
Baltimore, MarylandAges 18 years+ - NCT05795842Recruiting
Detecting atrial fibrillation after stroke using a wrist monitor
This study checks whether a special wrist device can detect an irregular heartbeat (atrial fibrillation) in people who recently had a stroke with an unclear cause. It may help doctors find the cause earlier and tailor follow-up care.
Atlanta, GeorgiaAges 55 years+ - NCT05948566RecruitingPhase 2
Improving response to stroke treatment with an antibody drug
This Phase 2 trial tests an antibody treatment (TS23) given to people with a suspected acute ischemic stroke to improve how well they respond to stroke care. You may qualify if your stroke scan shows the right pattern of injured brain tissue and if the study drug can be given within a short time window after symptoms start.
Birmingham, AlabamaAges 18 years+ - NCT06069973Recruiting
Using AI to spot delayed brain injury after a brain bleed
This study uses artificial intelligence (machine learning) and blood tests to find early signs of delayed brain injury after a brain bleed. It aims to help doctors detect and treat this complication sooner.
GothenburgAges 18–110 - NCT06224426Recruiting
Oxygen Levels for Stroke Patients Having Clot Removal
This trial tests whether giving a specific level of oxygen during a procedure to remove a stroke clot improves recovery. It is for people with a moderate to severe stroke in the front part of the brain, treated within 24 hours of symptoms starting.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06308952RecruitingPhase 4
Atorvastatin before flow diverter for brain aneurysms
This trial tests whether taking atorvastatin before a flow diverter procedure can prevent strokes or other brain events in people with unruptured brain aneurysms. It may help reduce complications from the treatment.
Guangzhou, GuangdongAges 18–75 - NCT06459388Recruiting
Balance training methods for stroke recovery
This study compares two types of physical therapy exercises to help stroke survivors improve balance and walking. One method uses arm and leg movements, while the other focuses on the pelvis area.
Lahore, Punjab ProvinceAges 40–65 - NCT06591299RecruitingPhase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
Kafr ash ShaykhAges 18–75 - NCT06591338RecruitingPhase 3
Aspirin plus ticagrelor or clopidogrel for minor stroke
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
Kafr ash ShaykhAges 18–75
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic stroke?
- Yes. Clin2 currently lists 577 recruiting ischemic stroke studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic stroke trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic stroke trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.